Cadillac

Researchers are evaluating patient-reported outcomes and unplanned healthcare use after ureteroscopic treatment for kidney and ureteral stones. This study compares outcomes between patients who receive a ureteral stent after surgery and those who do not. The trial includes both randomized and observational groups, with hypotheses focused on differences in pain interference and healthcare utilization between these groups. Participants in the randomized group are assigned to either receive a stent or have no stent placed, provided no complications occur during ureteroscopy. Patients in the observational group receive treatment decisions based on their physicians usual practice. The study excludes participants who experience certain complications during surgery, such as ureteral perforation or significant bleeding. During participation, patients complete surveys about pain, quality of life, and their experiences following ureteroscopy. Clinical data before, during, and after surgery are collected. The main outcomes measured include changes in pain interference at 7 to 10 days post-surgery and unplanned healthcare visits within 30 days. Additional assessments of pain, urinary symptoms, treatment satisfaction, and time off work are conducted up to 4 to 6 weeks after surgery.